Novo Nordisk’s next-gen obesity drug results a letdown for investors
CHICAGO — Late-stage results of Novo Nordisk’s obesity candidate CagriSema suggest the drug is comparable to Eli Lilly’s Zepbound on ...
CHICAGO — Late-stage results of Novo Nordisk’s obesity candidate CagriSema suggest the drug is comparable to Eli Lilly’s Zepbound on ...
A new long-term study published in BMJ Medicine suggests that children born to very obese mothers (those with a body ...
New research being presented at this year's European Congress on Obesity (ECO 2025) has found that patients of an online ...
Researchers at the Tohoku University Graduate School of Medicine have uncovered a key primary step in the hepatic ERK pathway ...
New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that ...
The pleasure we get from eating junk food - the dopamine rush from crunching down on salty, greasy French fries ...
Credit: CC0 Public Domain New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, ...
NEW YORK — In his first public comments, Pfizer’s new innovation chief — once a Wall Street analyst skeptical of ...
Roche is expanding its scope to a promising but competitive new obesity target, committing $1.65 billion up front to partner ...
What are the effects of plant-based meats on premature puberty, childhood obesity, and hip fracture risk? As noted in an ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.